| Test | Specification | Result |
| Appearance | White to gray-white powder | white powder |
| Purity,% | >=98.0% | 99.1% |
| Content | 98.0-102.0% | 99.8% |
| Loss on drying % | <=2.0% | 0.2% |
| A single impurity % | <0.1% | 0.1% |
| Ash | <=1.0% | 0.8% |
Ritifosinic acid is a drug used to treat hyperkinetic syndrome in children and can be obtained by catalytic reduction of alpha-aryl – -pyridine-2-group – acetamide, which is then hydrolyzed , by catalytic reduction of alpha-aryl – -pyridine-2-group – acetate or ester.
Packaging:25 kg/package , as customer’s request
Shipping:It can be according to the customer’s request
2-8°C
Ritdronic acid is a drug that can be used to treat children’s hyperactivity syndrome. It can be obtained by catalytic reduction of the formula α-aryl-α-pyridin-2-yl-acetamide, and then hydrolysis of the piperidinylacetamide produced. Obtained or obtained by catalytic reduction of α-aryl-α-pyridin-2-yl-acetate or ester.